Company profile

Ticker
VBIO
Exchange
CEO
Michael Cavanaugh
Employees
Incorporated in
Location
Fiscal year end
Former names
Legend Mining Inc., Stevia First Corp.
SEC CIK
IRS number
753268988

VBIO stock data

(
)

Calendar

13 Aug 19
25 Aug 19
31 Mar 20

News

Company financial data Financial data

Quarter (USD) Jun 19 Mar 19 Dec 18 Sep 18
Revenue 94.82K 36.51K
Net income -1.59M -9.56M -1.21M -1.22M
Diluted EPS -0.48 -0.04 -0.05
Net profit margin -1275% -3344%
Operating income -1.19M -9.57M -1.37M -1.18M
Net change in cash -1.31M -1.48M 7.13M 163.64K
Cash on hand 4.67M 5.98M 7.46M 336.68K
Cost of revenue 14.71K
Annual (USD) Mar 19 Mar 18 Mar 17 Mar 16
Revenue 258.29K 102.42K 163.36K 248.35K
Net income -13.12M -4.31M -5.22M -141.33K
Diluted EPS -0.61 -0.19 -0.38 -0.02
Net profit margin -5080% -4207% -3195% -56.91%
Operating income -13.23M -4.4M -3.47M -2.74M
Net change in cash 5.33M -496.48K 1.06M -294.3K
Cash on hand 5.98M 656.29K 1.15M 95.43K
Cost of revenue 77.94K 108.26K 149.48K

Financial data from company earnings reports

Financial report summary

?
Management Discussion
  • Our net loss during the three months ended June 30, 2019 was $1,591,279 compared to a net loss of $1,135,219 for the three months ended June 30, 2018. Included in net loss during the three months ended June 30, 2019, our discontinued operations incurred a loss of $450,027, compared to a loss of $55,695 in the 2018 period. We had no revenue from continuing operations during either the 2019 or 2018 period.
  • During the three months ended June 30, 2019, we incurred general and administrative expenses in the aggregate amount of $852,419 compared to $480,701 incurred during the three months ended June 30, 2018 (an increase of $371,718). General and administrative expenses generally include corporate overhead, salaries and other compensation costs, financial and administrative contracted services, marketing, consulting costs and travel expenses. The majority of the increase in general and administrative costs in the period relates to legal fees which increased to $270,875 in the period ending June 30, 2019, as compared to $82,943 in the period ending June 30, 2018.
  • In addition, during the three months ended June 30, 2019, we incurred research and development costs of $328,488, compared to $573,630 during the three months ended June 30, 2018 (a decrease of $245,142). This decrease resulted from decreased consulting expenses during the 2019 period.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: absorbed, absorption, accelerate, agent, animal, attach, binding, bioactive, blood, borrowing, broader, calendar, cannabidivarin, cannabinol, CBDV, CBN, CEO, characterized, clause, cleave, commonly, compatibility, complement, complementary, complied, compound, concentrated, constipation, corroborated, create, created, criteria, cumulative, damage, debilitating, decided, digestive, discretion, distinct, diversified, diversify, diversifying, Division, document, documentation, documented, dose, drink, duration, employed, equally, equipment, expertise, family, favorable, fewer, fill, flexible, flow, functional, glucose, greatly, growth, hand, hinder, holder, hydrolase, hypothetical, iii, implicit, important, inactive, incremental, IND, inflamed, inflection, ingestion, intact, intensive, irreversible, issuable, iv, kit, lead, learned, letter, leverage, Los, low, managerial, marketplace, mechanism, method, methodology, microbiota, minimizing, molecule, opportunistically, opportunity, optimal, overactive, partnership, percentage, pharmacokinetic, physiologically, point, polar, preclinicalin, prerequisite, prescribed, profile, promising, rapid, readily, remove, represent, represented, requisite, resale, respond, ROU, secreted, securing, simplify, single, solubility, soluble, stable, stage, stomach, stream, suffering, supplemental, surgery, testimony, tissue, transform, transit, understanding, unique, unmet, unpredictable, unrealized, unwanted, upper, virtually, vitroandin, vivo, Washington, water, whichever, written
Removed: abbreviated, achieved, acute, adjusted, administer, adult, advanced, advantage, advisory, aim, amortization, amplify, analyzed, anorexia, appetite, apply, approve, approved, assessing, Australia, authorized, autism, avoid, avoided, biotechnology, bloodstream, brain, brand, Brazil, breastfeeding, broad, Canada, cancer, cannaboside, case, CDAC, children, China, colonize, colorectal, commitment, comprehensive, computing, continued, contract, conventional, Cooperation, dedicated, deliver, delivered, demonstrated, Department, differentiated, discontinue, discount, dronabinol, earliest, earn, efficient, efficiently, eliminating, employee, employment, enforce, entry, Europe, event, eventual, examine, exclude, exclusive, Expedited, expensive, experienced, expired, extend, extensive, extensively, familiarity, feature, February, Food, forfeited, forfeiture, freestanding, generic, GI, granted, greater, gut, handling, healthy, Hedging, higher, history, hold, improvement, independently, indexed, induce, inducing, infringing, initiation, integral, internally, international, internationally, intoxication, investigated, involving, issuer, Japan, Justice, lapse, larger, licensing, line, MARINOLTM, mediating, mental, Mexico, microbiome, month, narcotic, nausea, NBS, neural, neurological, observational, older, opiate, opioid, organizational, overnight, Panel, patient, pediatric, periodically, permeability, pipeline, power, pregnant, preventing, prevention, primary, professional, profit, prosecution, prospective, protect, protection, psychoactivity, quickly, ranging, ratably, reached, receive, recipient, recommended, reduction, refractory, regional, registered, reliable, relief, relieve, repair, repayment, repeatedly, requiring, researching, restriction, revised, round, satisfaction, satisfied, schedule, selling, separately, September, set, settled, site, sleep, spectrum, spend, sponsor, straight, strike, strongly, studied, study, submitted, substitution, successful, suite, supporting, targeting, termination, therapy, titled, today, tolerability, treat, treating, Treaty, TRPV, ultimately, unlocking, unvested, vanilloid, verification, version, vest, vested, visceral, vomiting, widespread, Zealand